Related by context. All words. (Click for frequent words.) 72 T DM1 72 axitinib 72 glufosfamide 69 Amrubicin 69 Tarceva erlotinib 69 Canvaxin 69 BAY #-# 68 tesmilifene 68 ixabepilone 68 elotuzumab 68 Targretin 68 Telcyta 68 cediranib 68 picoplatin 68 vandetanib 68 phase IIb 68 enzastaurin 67 pertuzumab 67 panitumumab 67 HuMax CD# 67 Aplidin 67 figitumumab 67 HuMax EGFr 67 lintuzumab 67 ocrelizumab 67 PXD# 67 BRIM2 67 Xyotax 67 Zactima 67 afatinib 67 bevacizumab Avastin 67 temsirolimus 67 perifosine 67 Ceflatonin 66 talactoferrin 66 TroVax 66 Erbitux 66 OncoVEX GM CSF 66 Allovectin 7 66 Vectibix 66 cetuximab Erbitux 66 neratinib 66 Avastin bevacizumab 66 aflibercept 66 Dacogen injection 66 ProSavin 66 trastuzumab DM1 66 Aflibercept 66 phase Ib 66 almorexant 66 L BLP# 66 Nexavar sorafenib 66 FTY# 66 EndoTAG TM -1 66 carfilzomib 66 PTK ZK 66 Revlimid lenalidomide 66 Lupuzor 65 Advexin 65 Erbitux cetuximab 65 Mipomersen 65 Actemra 65 dacetuzumab 65 ganetespib 65 Panitumumab 65 ASONEP 65 abiraterone 65 HuMax CD4 65 XmAb# 65 Hycamtin 65 YONDELIS 65 Satraplatin 65 GV# [001] 65 obatoclax 65 entinostat 65 ridaforolimus 65 LUX Lung 65 Dacogen 65 PROSTVAC TM 65 olaparib 65 eltrombopag 65 Phase Ib clinical 65 HGS ETR1 65 Folotyn 65 phase IIb clinical 65 Dasatinib 65 Tavocept 65 eprotirome 65 vemurafenib 65 MDV# 65 Stimuvax 65 XL# [003] 65 seliciclib 65 valopicitabine 65 iclaprim 65 iniparib 65 ofatumumab 64 talabostat 64 gefitinib Iressa 64 dasatinib 64 Herceptin trastuzumab 64 adecatumumab 64 motesanib 64 BRAF inhibitor 64 regorafenib 64 Velcade 64 LymphoStat B 64 BRIM3 64 Pfizer Sutent 64 Nexavar 64 alvespimycin 64 sapacitabine 64 amrubicin 64 GVAX 64 Glufosfamide 64 sorafenib 64 HuLuc# 64 Abiraterone 64 Phase Ib II 64 metastatic renal cell carcinoma 64 ELACYT 64 TG# [001] 64 tremelimumab 64 pazopanib 64 Epratuzumab 64 Syncria 64 Ixempra 64 daclizumab 64 Vitaxin 64 AP# [003] 64 Theratope 64 sunitinib malate 64 HER2 positive metastatic breast 64 Vandetanib 64 cetuximab 64 metaglidasen 64 ISEL 64 Tarvacin 64 Pirfenidone 64 Recentin 64 Phase Ib 64 Tykerb 64 bendamustine 64 IMA# 64 Tocosol Paclitaxel 64 sorafenib Nexavar 64 Desmoteplase 64 Proxinium TM 64 phase IIa clinical 64 mertansine 64 registrational trial 64 Removab 63 TASQ 63 gefitinib 63 atrasentan 63 Taxotere ® 63 adjuvant colon cancer 63 Abraxane 63 Azixa 63 tocilizumab 63 Archexin 63 Ocrelizumab 63 Torisel 63 oral ridaforolimus 63 satraplatin 63 Avastin 63 farletuzumab 63 Arzerra 63 RG# [001] 63 Pazopanib 63 ularitide 63 ZACTIMA 63 vascular disrupting agent 63 deforolimus 63 Carfilzomib 63 phase IIa 63 AEG# 63 Mylotarg 63 Xanafide 63 Antisoma 63 mapatumumab 63 OPAXIO 63 darapladib 63 Tarceva 63 Velcade bortezomib 63 MGCD# [001] 63 Juvista 63 pemetrexed 63 zanolimumab 63 Panzem R NCD 63 zibotentan 63 sunitinib 63 Xinlay 63 Gefitinib 63 pradefovir 63 Treanda 63 Yondelis 63 ImClone Erbitux 63 BCX# 63 CytoFab 63 romidepsin 63 dirucotide 63 Phase 1b 63 Neuvenge 63 Tyrima 63 Genasense 63 NVA# 63 Sutent 63 Orazol 63 Pertuzumab 63 Zolinza 63 docetaxel Taxotere R 63 LAF# 63 Alpharadin 63 Celgene Revlimid 63 Telaprevir 63 Azedra 63 ACTEMRA 63 Hepatocellular Carcinoma HCC 63 Votrient 63 Reverset 63 vicriviroc 63 docetaxel chemotherapy 63 Troxatyl 63 Revlimid 62 multicenter Phase 62 TELCYTA 62 ATL# [001] 62 lapatinib 62 CR# vcMMAE 62 SNT MC# 62 IMC A# 62 Cloretazine ® 62 RGB # 62 Lapatinib 62 Bortezomib 62 Tesmilifene 62 AVOREN 62 IMC #B 62 methylnaltrexone 62 elesclomol 62 midstage studies 62 IMGN# 62 Tarceva TM 62 teriflunomide 62 huC# DM4 62 OvaRex ® MAb 62 romiplostim 62 Exherin TM 62 SUTENT 62 elacytarabine 62 Quinamed 62 Sorafenib 62 Fludara 62 Panzem 62 Sym# 62 Bicifadine 62 PF # [001] 62 Alemtuzumab 62 Perifosine 62 EOquin TM 62 Marqibo 62 TOCOSOL Paclitaxel 62 clofarabine 62 Insegia 62 Reolysin 62 rNAPc2 62 trabectedin 62 goserelin 62 tanespimycin 62 INCB# [001] 62 Phase 2b clinical 62 JAK inhibitor 62 brentuximab vedotin 62 NSCLC 62 CBLC# 62 registrational 62 phase IIb trial 62 gemcitabine chemotherapy 62 Zalbin 62 Virulizin R 62 Vectibix panitumumab 62 ISIS # 62 bosutinib 62 Phase 2a trial 62 Atrasentan 62 Clolar 62 TNFerade 62 CoFactor 62 PLX# 62 ToGA 62 EndoTAGTM 1 62 lapatinib Tykerb 62 cabazitaxel 62 erlotinib Tarceva 62 Arixtra 62 XYOTAX 62 Eribulin 62 EOquin 62 custirsen 62 imetelstat 62 Zerenex 62 VEGF Trap 62 Onrigin 62 Serdaxin 62 abiraterone acetate 62 ospemifene 62 Virulizin 62 Nexavar ® 62 Annamycin 61 lumiliximab 61 nilotinib 61 erlotinib 61 Asentar 61 IRESSA 61 Phase III 61 BNC# 61 Allovectin 7 ® 61 Campath 61 OXi# 61 SinuNase 61 Golimumab 61 AZD# 61 Omnitarg 61 Taxotere 61 Amigal 61 pralatrexate 61 Ceflatonin R 61 Promacta 61 TREANDA 61 voreloxin 61 Xelox 61 Iressa gefitinib 61 Phase Ib study 61 radiation sensitizer 61 Temsirolimus 61 Jevtana 61 Bevacizumab 61 baminercept 61 lixisenatide 61 placebo controlled Phase 61 dose escalation Phase 61 Phase 2b trial 61 PEG Interferon lambda 61 Phase 2b study 61 trastuzumab DM1 T DM1 61 vorinostat 61 trastuzumab Herceptin 61 mipomersen 61 Imprime PGG 61 BLP# Liposome Vaccine 61 FOLOTYN 61 Erlotinib 61 Viramidine 61 zalutumumab 61 HGS ETR2 61 Emselex 61 metastatic RCC 61 phase 2a 61 Phenoptin 61 CDP# 61 Ziopharm 61 decitabine 61 belinostat 61 Antegren 61 Pemetrexed 61 randomized Phase 61 Debio 61 PRT# 61 pomalidomide 61 Cloretazine R VNP#M 61 ipilimumab 61 Aurexis 61 cilengitide 61 Taxotere docetaxel 61 Vidaza 61 fostamatinib 61 Gleevec imatinib mesylate 61 Novartis Zometa 61 GALNS 61 Phase 2b 61 UVIDEM 61 low dose cytarabine 61 KRN# 61 cangrelor 61 midstage clinical 61 forodesine 61 Sanofi Aventis Taxotere 61 Daclizumab 61 otelixizumab 61 alemtuzumab Campath 61 ozarelix 61 TroVax ® 61 SAR# [004] 61 TMC# [002] 61 Relovair 61 bapineuzumab 61 ImmuPharma 61 Phase IIa trials 61 Femara 61 Plicera 61 Vilazodone 61 Afatinib 61 Safinamide 61 ADVEXIN 61 Dapagliflozin 61 BrachySil 61 mTOR inhibitor 61 blinatumomab 61 AQ4N 61 elagolix 61 anastrozole 61 ProLindac 61 Alocrest 61 MAGE A3 ASCI 61 Phase 2a 61 UPLYSO 60 DASISION 60 YERVOY 60 BCIRG 60 Nuvion 60 Ambrisentan 60 standard chemotherapy regimen 60 ACZ# 60 PEG SN# 60 Genentech Roche 60 rindopepimut 60 Onconase 60 DMXAA 60 MYDICAR ® 60 Synavive 60 Phase IIb clinical 60 canakinumab 60 Phase III trials 60 MyVax 60 NO# [002] 60 APPRAISE 60 L MTP PE 60 anti TNF 60 panitumumab Vectibix 60 topotecan 60 Æterna Zentaris 60 monotherapy 60 clazosentan 60 Rezular 60 SUCCEED trial 60 Phase IIB 60 ALD# 60 Cimzia 60 oral fludarabine 60 oral Xeloda 60 relapsed SCLC 60 Dendreon Provenge 60 FOLFIRI 60 laquinimod 60 relapsed ovarian cancer 60 APOPTONE 60 Onyx Pharma 60 angiogenesis inhibitor 60 GSK# [001] 60 Clofarabine 60 EFAPROXYN 60 Virulizin ® 60 PLK1 SNALP 60 carboplatin paclitaxel 60 mifamurtide 60 recurrent NSCLC 60 atacicept 60 pegylated interferons 60 EndoTAG 60 Corlux 60 Santhera 60 RAD# everolimus 60 PF # [002] 60 GRN# 60 RP# [002] 60 Xcytrin 60 TRISENOX 60 CRLX# 60 Clavis Pharma 60 rivaroxaban 60 VIDAZA 60 CA4P 60 platinum refractory 60 #D#C# 60 tamibarotene 60 docetaxel 60 riociguat 60 Trastuzumab 60 Cladribine 60 KRAS status 60 alvimopan 60 randomized Phase IIb 60 ELND# 60 Afinitor 60 tafamidis 60 omacetaxine 60 anidulafungin 60 OncoVEX 60 mRCC 60 Summary Genmab 60 ADVANCE PD 60 Randomized Phase 60 OncoGel 60 RAD# [003] 60 Roche Xeloda 60 Valdoxan 60 ERBITUX 60 safinamide 60 XGEVA 60 Evoltra 60 pegylated liposomal doxorubicin 60 Oncophage 60 HGS# 60 advanced NSCLC 60 squamous non 60 bardoxolone 60 Zarnestra 60 Acapodene 60 YONDELIS R 60 PROMACTA 60 oral antiviral 60 Helsinn Healthcare 60 tesetaxel 60 Phase III clinical 60 PSMA ADC 60 celgosivir 60 MAXY alpha 60 triphendiol 60 INCB# [002] 60 ThermoDox R 60 Genentech Avastin 59 OHR/AVR# 59 LCP AtorFen 59 Exelixis XL# 59 bicifadine 59 epothilone 59 nonsmall cell lung cancer 59 Ixabepilone 59 Iressa 59 Riquent 59 receptor tyrosine kinase inhibitor 59 Pimavanserin 59 Laquinimod 59 apaziquone 59 Aurora kinase inhibitor 59 MOZOBIL 59 Abatacept 59 palonosetron 59 ILLUMINATE 59 Allovectin 7 R 59 Gemzar ® 59 multicenter Phase II 59 randomized Phase 2b 59 eniluracil 59 Evoltra TM 59 lurasidone 59 ZYBRESTAT 59 Affinitak 59 MEK inhibitors 59 Phase #b/#a 59 DXL# 59 Liraglutide 59 cutaneous T cell 59 Everolimus 59 Doxil 59 bevacizumab 59 Lu AA# 59 Factor VIIa 59 Cetrorelix 59 refractory AML 59 taranabant 59 anti EGFR antibody 59 Neurodex 59 Cloretazine 59 azacitidine 59 AVADO 59 Candesartan 59 REOLYSIN ® 59 Fibrillex TM 59 ambrisentan 59 Phase IIb trial 59 Fodosine 59 Genentech Herceptin 59 Arcalyst 59 motavizumab 59 rALLy trial 59 brivaracetam 59 drug figitumumab 59 maribavir 59 cetrorelix 59 depsipeptide 59 relapsed multiple myeloma 59 Rituxan 59 Halaven 59 seliciclib CYC# 59 sargramostim 59 ZD# [001] 59 ATL/TV# 59 velafermin 59 Tamibarotene 59 CVac 59 tramiprosate Alzhemed TM 59 Lenalidomide 59 Catena ® 59 STRIDE PD 59 DU #b 59 Arranon 59 Atiprimod 59 Muraglitazar 59 Civacir 59 QAB# 59 XELOX 59 TBC# 59 evaluating tivozanib 59 ZOLINZA 59 metastatic colorectal 59 LymphoStat B TM 59 proteasome inhibitor 59 TYKERB 59 Numax 59 Tanespimycin 59 Dacogen decitabine 59 CytoFabTM 59 APTIVUS 59 Phase IIb 59 Maraviroc 59 Rasilez Tekturna 59 palifosfamide 59 Urocidin 59 ONGLYZA ™ 59 Intravenous CP 59 Pixantrone 59 pemetrexed Alimta 59 QVA# 59 trastuzumab emtansine T DM1 59 BEMA TM Fentanyl 59 XL# XL# XL# 59 relapsed refractory multiple myeloma 59 Genasense ® 59 LY# [003] 59 BiovaxID 59 metastatic HRPC 59 IRX 2 59 Addex 59 Phase IIa clinical 59 bortezomib 59 brentuximab vedotin SGN 59 Vidaza azacitidine 59 CIMZIA TM 59 metastatic hormone refractory 59 XYOTAX TM 59 reslizumab 59 dapagliflozin 59 Ofatumumab 59 Zybrestat 59 BEXXAR 59 lorvotuzumab mertansine 59 EGFR TKI 59 RSR# 59 BIBW 59 febuxostat 59 paclitaxel Taxol 59 RhuDex ® 59 MYDICAR 59 tezampanel 59 betrixaban 59 M6G 59 TASKi3 59 Targeted Chemotherapy 59 ANTEGREN 59 GLP toxicology studies 59 bazedoxifene 59 PDE4 inhibitor 59 FOLFOX 59 docetaxel Taxotere 59 Irinotecan 59 Traficet EN 59 Prostate AdenoCarcinoma Treatment 59 epratuzumab 59 ongoing Phase 1b 59 Voreloxin 59 Ceflatonin ® 59 oral FTY# 59 tyrosine kinase inhibitor 59 OvaRex 59 telcagepant 59 trastuzumab 59 denufosol 59 CYC# 59 asenapine 59 AVASTIN 59 bortezomib Velcade 59 randomized Phase III 59 Vion Pharmaceuticals 59 HRPC 59 Trovax 58 Phase IIb trials 58 biologic therapy 58 Aurora kinase 58 Azedra TM 58 galiximab 58 Ozarelix 58 pirfenidone 58 Restanza 58 Cinquil 58 AEZS 58 Loramyc R 58 HCD# [002] 58 NXL# 58 vosaroxin 58 investigational humanized monoclonal antibody 58 apremilast 58 telbivudine 58 Pralatrexate 58 KNS # 58 GRN#L 58 metastatic colorectal cancer 58 midstage trials 58 tolevamer 58 oxaliplatin 58 muraglitazar 58 metastatic CRC 58 Fablyn 58 fipamezole 58 BZL# 58 dexanabinol 58 Phase IIIb clinical 58 pediatric acute lymphoblastic 58 investigational monoclonal antibody 58 TACI Ig 58 Stimuvax R 58 danoprevir 58 immatics 58 Phase IIa trial 58 orBec 58 Mycograb 58 FOLOTYN ® 58 TEMODAL 58 ONTAK 58 gastrointestinal stromal tumors 58 Adventrx 58 sipuleucel T 58 ofatumumab HuMax CD# 58 ONCONASE 58 cancer immunotherapies 58 Orathecin 58 Bezielle 58 heavily pretreated 58 dabigatran etexilate 58 metastatic renal cell 58 LBH# 58 multicenter randomized Phase 58 TMC# [001] 58 TORISEL 58 antibody MAb 58 rituximab 58 Motesanib 58 WILEX 58 Pixuvri 58 HER2 positive breast cancer 58 AZILECT R 58 oral prodrug 58 Campath alemtuzumab 58 anti leukemic 58 Telatinib 58 samalizumab 58 AEGR 58 ancrod 58 Atacand 58 cabozantinib 58 Brentuximab Vedotin SGN 58 ANYARA 58 anticancer compound 58 Roche Avastin 58 Docetaxel 58 OncoVex 58 Ventavis 58 Trastuzumab DM1 58 Exemestane 58 experimental hepatitis C 58 SCH # 58 Tolamba 58 Gemcitabine 58 PROVENGE 58 Kynapid 58 Nanobody 58 Pivotal Phase 58 EGFR inhibitors 58 Neulasta ® 58 posaconazole 58 Rituxan rituximab 58 telaprevir 58 volociximab 58 Teysuno 58 ProMune 58 Gattex 58 dose escalation clinical 58 Merck KGaA Erbitux 58 Cogane 58 DPX Survivac 58 antisense drug 58 MabCampath 58 ponatinib 58 Elagolix 58 NEVO ™ 58 recurrent ovarian cancer 58 sorafenib Nexavar R 58 Romidepsin 58 Vernakalant 58 allosteric modulator 58 Sutent sunitinib 58 Aptivus ® 58 isavuconazole 58 Belinostat 58 Alimta 58 MabThera 58 Oglemilast 58 infusional 5-FU/LV 58 albinterferon alfa 2b 58 HER2 positive 58 gemcitabine 58 Tasigna nilotinib 58 Phase #/#a trial 58 tivozanib 58 PRECiSE 58 randomized controlled Phase 58 metastatic castrate resistant 58 Sprycel 58 Diamyd ® 58 Pegintron 58 PREOS 58 cancer mCRC 58 CLL8 58 Guanilib 58 Boceprevir 58 stage IIIB IV 58 Angiolix 58 TASKi2 58 prasugrel 58 Neuradiab 58 crizotinib PF # 58 HIV integrase inhibitor 58 telomerase therapeutic 58 Exelixis compounds 58 ImmunoVEX HSV2 58 MKC# PP 58 anti angiogenic therapy 58 liver metastases 58 PrevOnco 58 interferon gamma 1b 58 GeneICE 58 cisplatin vinorelbine 58 cariprazine 58 Heplisav 58 Camptosar 58 oral deforolimus 58 Leukine 58 Specifid 58 MERLIN TIMI 58 dimebon 58 HQK 58 Bayer HealthCare Onyx Pharmaceuticals 58 Tyverb 58 Olaparib 58 VELCADE 58 Viprinex 58 taspoglutide 58 temozolomide 58 Varisolve 58 Yervoy 58 sorafenib Nexavar ® 58 dalbavancin 58 BioNumerik 58 golimumab 58 Phase 1a clinical 58 Trabectedin 58 IL# PE#QQR 58 PS# [001] 58 NV1FGF 58 oral taxane 58 Bonefos 58 erlotinib Tarceva ® 58 chronic lymphocytic leukemia CLL 58 Ilaris 58 Hsp# inhibition 58 bevacizumab Avastin ® 58 Sapacitabine 58 Sulonex 58 BLA filing 58 KIACTA ™ 58 Phase III VISTA 58 Provecta 58 Cetuximab 58 Roche Actemra 58 MyVax personalized immunotherapy 58 tipranavir 57 MyVax R 57 Bayer Nexavar 57 XL# XL# XL# XL# 57 Vicriviroc 57 unresectable stage 57 systemic ALCL 57 R#/MEM # 57 eculizumab 57 HCV SPRINT 57 Hexvix 57 refractory multiple myeloma 57 phase IIb study 57 Aromasin 57 histone deacetylase HDAC inhibitor 57 Medullary Thyroid Cancer 57 epigenetic therapies 57 enoximone 57 thymalfasin 57 Sunitinib 57 TYZEKA 57 Vectibix monotherapy 57 Campath ® 57 Gliadel Wafer 57 ACTEMRA TM 57 Pivotal Phase III 57 faropenem 57 glatiramer 57 Clolar ® 57 IMPACT IMmunotherapy 57 clinical trial 57 Mepact 57 Firazyr 57 Betaferon ® 57 proteasome inhibitor bortezomib 57 Tocosol 57 Arimoclomol 57 Phase 1b clinical 57 Gemzar 57 ximelagatran 57 Phase IIb clinical trials 57 Aliskiren 57 adalimumab Humira 57 NLX P# 57 Proellex TM 57 CCX# 57 PARP inhibitor 57 tipifarnib 57 INTEGRILIN 57 Scancell 57 CYT# 57 pegloticase 57 torezolid phosphate 57 Loramyc ® 57 EGFr 57 ICON7 57 orally bioavailable 57 Phase 2a clinical 57 antitumor activity 57 Seattle Genetics SGEN 57 investigational compounds 57 ABX EGF 57 nab paclitaxel 57 Gilenia 57 NATRECOR R 57 taxane chemotherapy 57 arzoxifene 57 Asenapine 57 Vorapaxar 57 pain palliation 57 JP-#/fipamezole 57 CD# monoclonal antibody 57 Hycamtin ® 57 CIMZIA ™ 57 thalidomide Thalomid 57 OMAPRO 57 cytokine refractory 57 non squamous 57 squamous histology 57 Bronchitol 57 IV NSCLC 57 PCK# 57 vilazodone 57 CD# antibody [001] 57 anticancer therapy 57 abatacept Orencia 57 ustekinumab 57 Oxaliplatin 57 Lorianne Masuoka MD 57 ZK EPO 57 Crizotinib 57 MLN# 57 MabThera rituximab 57 LEUKINE 57 evaluating REVLIMID 57 Tracleer 57 Triolex 57 metastatic castration resistant 57 zoledronic acid 57 PROSTVAC ® 57 Evoltra ® 57 vinflunine 57 ceftaroline